BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 12345576)

  • 1. Expanded role for OCs. Question and answer.
    Mishell Dr
    Dialogues Contracept; 1994; 4(3):8. PubMed ID: 12345576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL; Peterson HB
    Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptives have beneficial effects.
    PIACT Prod News; 1982 Aug; 4(2):1, 4. PubMed ID: 12311600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dispelling OC myths and misperceptions.
    Grimes DA
    Dialogues Contracept; 1994; 4(3):1-4. PubMed ID: 12345574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral contraception and its beneficial gynecological effects].
    Belaisch J; Hommais-loufrani B
    Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to end bias against the pill.
    Potts M
    Entre Nous Cph Den; 1992 May; (20):10-1. PubMed ID: 12222224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects.
    United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices
    Netw Res Triangle Park N C; 1986; 7(4):1-5. PubMed ID: 12341093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OCs and genital tract malignancies.
    Herbst AL
    Dialogues Contracept; 1994; 4(3):5-7. PubMed ID: 12345575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The myth about contraceptives and breast cancer.
    Ibekwe J
    Dly Times; 1993 Mar; ():7. PubMed ID: 12179509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoplastic effects of oral contraceptives.
    Grimes DA
    Int J Fertil; 1991; 36 Suppl 1():19-24. PubMed ID: 1678377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disease and contraception. Recent aspects].
    Rozenbaum H
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):431-6. PubMed ID: 12280211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptives and breast cancer: any relationship?
    Peterson HB; Wingo PA
    Contemp Oncol; 1992 Dec; 2(10):13-14, 19-20, 2. PubMed ID: 12345964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-contraceptive benefits of oral contraceptives.
    Prog Hum Reprod Res; 1996; (39):6-7. PubMed ID: 12292200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments].
    Le Coutour X
    NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraception: where do we stand?
    Diczfalusy E
    Contemp Rev Obstet Gynaecol; 1992 Jul; 4(3):148-53. PubMed ID: 12287020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks of oral contraceptive use in women over 35.
    Stenchever MA
    J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The noncontraceptive health benefits from oral contraceptive use.
    Ory HW
    Fam Plann Perspect; 1982; 14(4):182-4. PubMed ID: 7117506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
    Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OCs protect users against PID, study shows.
    Contracept Technol Update; 1981 Aug; 2(8):101-2. PubMed ID: 12337621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives and cancer of the reproductive organs.
    Huezo C
    IPPF Med Bull; 1985 Dec; 19(6):3-4. PubMed ID: 12267511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.